3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pancreatic Neoplasms
54
Biliary Tract Neoplasms
23
Nasopharyngeal Carcinoma
22
Carcinoma, Non-Small-Cell Lung
22
Cholangiocarcinoma
21
Urinary Bladder Neoplasms
18
Breast Neoplasms
18
Neoplasm Metastasis
17
Lung Neoplasms
14
Lymphoma, Large B-Cell, Diffuse
13
Colorectal Neoplasms
12
Carcinoma, Transitional Cell
12
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
8
Ovarian Neoplasms
8
Triple Negative Breast Neoplasms
7
Sarcoma
7
Neoplasms
6
Hodgkin Disease
6
Gallbladder Neoplasms
6
Nasopharyngeal Neoplasms
5
Bile Duct Neoplasms
5
Adenocarcinoma
5
Uterine Cervical Neoplasms
4
Locally Advanced Pancreatic Cancer
4
Endometrial Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Adenocarcinoma
3
Osteosarcoma
3
Lymphoma
3
Interventions
zanidatamab
1
tislelizumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Muscle Invasive Bladder Cancer (MIBC)
×
Gemcitabine
×
Clear all
NCT07296705
2025-12-22
HARBOR
Fujian Medical University Union Hospital
Phase 2
Recruiting
25 enrolled